Odisha Education Minister Nityananda Gond said the government is cautious about COVID-19 and that teachers should be trained to prevent COVID-19 infection when exposure to the virus cannot be avoided.
ICMR Director General Dr. Rajiv Bahl stated that COVID-19 infections are currently mild with low active cases, primarily in southern and western India. Surveillance and preparedness measures are underway, and the government remains vigilant.
The Chief Minister reassured the public that there is no immediate cause for concern in the state; however, he emphasised that, given the global context, vigilance and precaution remain essential.
New Delhi [India], February 20: As COVID-19 continues to evolve into new variants, it is clear that the virus is here to stay. With vaccines no longer at the center of public discourse and their safety is in question against emerging variants, it's time for the global community to explore vi
Experts believe China will continue to experience various respiratory pathogens alternating or co-circulating in the winter and the coming spring, with influenza viruses still dominating in the short term.
Paxlovid (Nirmatrelvir-ritonavir) did not decrease the chance of developing long COVID in vaccinated, non-hospitalized patients during their initial COVID-19 infection, according to a team of UC San Francisco researchers. They also discovered a larger number of people with acute symptoms reb
India recorded 775 fresh cases of COVID-19 in the last 24 hours. The total active caseload decreased by 17, reaching 4,423, in the last 24 hours, according to the Union Health Ministry.
Amid the rising heart attack cases in the country, Union Health Minister Mansukh Mandaviya has said that people who have suffered from severe COVID-19 infection should not do hard work exercises for some time to avoid heart attacks.
According to new research from King's College London, people with severe mental illness are more likely to die from any cause after contracting COVID-19 than those who do not have severe mental illness.
Research from the Francis Crick Institute, the University of Cambridge, Imperial College London, the University of Liverpool, the University of Cape Town, and UKHSA has linked molnupiravir, an antiviral drug for COVID-19 infections, and a pattern of mutations in the SARS-CoV-2 virus.